enow.com Web Search

  1. Ads

    related to: symptoms of relapsing remitting ms treatment guidelines

Search results

  1. Results from the WOW.Com Content Network
  2. Management of multiple sclerosis - Wikipedia

    en.wikipedia.org/wiki/Management_of_multiple...

    In March 2020, ozanimod (Zeposia) was approved in the United States for the treatment of relapsing multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. [9] [52] [53] [54]

  3. Signs and symptoms of multiple sclerosis - Wikipedia

    en.wikipedia.org/wiki/Signs_and_symptoms_of...

    Main symptoms of multiple sclerosis Symptoms and findings in multiple sclerosis. Multiple sclerosis can cause a variety of symptoms varying significantly in severity and progression among individuals: changes in sensation (hypoesthesia), muscle weakness, abnormal muscle spasms, or difficulty moving; difficulties with coordination and balance; problems in speech or swallowing (), visual ...

  4. Multiple sclerosis - Wikipedia

    en.wikipedia.org/wiki/Multiple_sclerosis

    It is also used for the treatment of relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. [156]

  5. Relapsing–remitting - Wikipedia

    en.wikipedia.org/wiki/Relapsingremitting

    The term is used to describe a type of multiple sclerosis called relapsingremitting multiple sclerosis, where unpredictable relapses are followed by remission for months to years. [ 1 ] The term is also used to describe palindromic rheumatism in the context of rheumatoid arthritis , [ 2 ] catatonia , [ 3 ] [ 4 ] lupus , [ 5 ] mental ...

  6. Ocrelizumab - Wikipedia

    en.wikipedia.org/wiki/Ocrelizumab

    In February 2016, the US Food and Drug Administration (FDA) granted breakthrough therapy designation for primary progressive multiple sclerosis. [21] In March 2017, the FDA approved ocrelizumab for relapsing-remitting and primary-progressive multiple sclerosis. It is the first FDA-approved treatment for the primary progressive form.

  7. Interferon beta-1a - Wikipedia

    en.wikipedia.org/wiki/Interferon_beta-1a

    The earliest clinical presentation of relapsing-remitting multiple sclerosis is the clinically isolated syndrome (CIS), that is, a single attack of a single symptom. During a CIS, there is a subacute attack suggestive of demyelination which should be included in the spectrum of MS phenotypes. [ 13 ]

  1. Ads

    related to: symptoms of relapsing remitting ms treatment guidelines